Share Price, page-4913

If you think about it, it would have to be a very complex decision. Not only are you evaluating financial aspects of the offer, whether to split the license into areas or not, whether each company has the logistical capacity and resources to perform etc
But then Neuren HAS to do their own independent due diligence to determine whether what’s being offered is actually a reality or ‘promises’ from the company.
We do not want to get into a situation where a company is granted a license and can’t produce or hit time line targets, doesn’t roll with trofinetide as a priority etc
Those details in my opinion is far more important than some slight variances in upfronts or royalties.
They will make the decision when they are 1000% sure. That’s because Neuren are run by experts